Meclizine Hydrochloride
Product Images NDC 67296-1849

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Meclizine Hydrochloride (NDC 67296-1849). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 01)

FDA Label Image

Logo (Image 02)

FDA Label Image

Label-12.5 mg (Image 03)

NDC 62559-841-01 is a prescription medicine in the form of Meclizine Hydrochloride USP Tablets. Each tablet contains 12.5 mg meclizine dihydrochloride equivalent to 10.58 mg of meclizine free base. It is used for VERTIGO and the recommended dosage should be determined by a healthcare professional. It should be dispensed in a tight, light-resistant container and stored within a controlled room temperature. This medicine should be kept out of the reach of children. It is manufactured by ANI Pharmaceuticals Canada, Inc. and distributed by ANI Pharmaceuticals, Inc.*

FDA Label Image

Label-25 mg (Image 04)

NDC 62559-842-01 Meclizine Hydrochloride Tablets USP is a prescribed medication used for the treatment of vertigo. The medication comes in 100 tablets containing 25 mg of meclizine dihydrochloride. The dosage is determined by clinical response but is usually between 25 mg to 100 mg per day. The medication should be kept out of reach of children and stored in a tight, light-resistant container as defined in the USP. ANI Pharmaceuticals Canada manufactures, and ANI Pharmaceuticals Inc. distributed it.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.